title: Hiccups with high dose dexamethasone administration: a case report.
abstract: BACKGROUND
  A 59-year-old male developed intractable hiccups during monthly therapy with high dose dexamethasone for multiple myeloma. Hiccups would begin hours after his first dose and continue over the 4 days of therapy. He sought assistance after his attempt at home remedies failed and the hiccups became exhausting.
  
  
  METHODS
  The strong temporal relation between dexamethasone administration and the occurrence of hiccups indicated that dexamethasone was the cause of the patient's hiccups. Because he was responding to dexamethasone, the decision was made to continue therapy and to relieve his hiccups with metoclopramide.
  
  
  RESULTS
  Low dose oral metoclopramide allowed the patient to continue therapy without a recurrence of the hiccups.
  
  
  CONCLUSIONS
  Dexamethasone administration can result in intractable hiccups that persist for the duration of therapy. Low dose oral metoclopramide may prevent hiccups in patients in whom the discontinuation of dexamethasone therapy is not appropriate.
authors.affiliation: Department of Pharmacy Practice, Bouve College of Pharmacy & Health Sciences, Northeastern University, Boston, Massachusetts 02115, USA.
authors.forename: R J
authors.initials: RJ
authors.lastname: Cersosimo
authors.forename: M T
authors.initials: MT
authors.lastname: Brophy
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects*; D018492:Dopamine Antagonists / Q000627:therapeutic use; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006606:Hiccup / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D018492:Dopamine Antagonists; D005938:Glucocorticoids; D003907:Dexamethasone; D008787:Metoclopramide